Showing results (111-120 of 130) with videos related to
Sort By:
Pageof 13
Current Rheumatology Reports|November 26, 2025
Development of 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-A/B Report: Defining and Structuring the Clinical and Laboratory DomainsMedha Barbhaiya, Stephane Zuily, Mary-Carmen Amigo, et al.The Journal of Experimental Medicine|April 10, 2019
Longitudinal profiling of human blood transcriptome in healthy and lupus pregnancySeunghee Hong, Romain Banchereau, Bat-Sheva L Maslow, et al.Advances in Rheumatology (London, England)|October 29, 2021
Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repositoryErivelton de Azevedo Lopes, Gustavo Guimarães Moreira Balbi, Maria G Tektonidou, et al.Arthritis Care & Research|September 28, 2020
Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and RepositoryEcem Sevim, Diane Zisa, Danieli Andrade, et al.Lupus|July 25, 2020
Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION RegistryStéphane Zuily, Isabelle Clerc-Urmès, Cédric Bauman, et al.Rheumatology (Oxford, England)|October 18, 2024
ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository ("Registry")Irene Cecchi, Massimo Radin, Silvia Grazietta Foddai, et al.Arthritis & Rheumatology (Hoboken, N.J.)|March 2, 2023
Anti-Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody-Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and RepositoryYu Zuo, Sherwin Navaz, Alex Tsodikov, et al.Rheumatology (Oxford, England)|June 12, 2023
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registryGustavo G M Balbi, Yasaman Ahmadzadeh, Maria G Tektonidou, et al.Journal of Thrombosis and Haemostasis : JTH|August 1, 2019
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repositoryMaria Efthymiou, Ian J Mackie, Philip J Lane, et al.Seminars in Arthritis and Rheumatism|June 3, 2019
The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohortMassimo Radin, Savino Sciascia, Doruk Erkan, et al.Pageof 13